• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why ParaZero Technologies Shares Are Trading Higher By Over 100%? Here Are Other Stocks Moving In Monday's Mid-Day Session

    10/9/23 1:30:06 PM ET
    $AAOI
    $ADXN
    $AWIN
    $BMY
    Semiconductors
    Technology
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $AAOI alert in real time by email

    Gainers

    • ParaZero Technologies Ltd. (NASDAQ:PRZO) shares jumped 106% to $2.3901 after the company announced an Australian regulator approved first commercial drone flights in populated areas and near people using ParaZero safety systems.
    • HUB Cyber Security Ltd. (NASDAQ:HUBC) shares jumped 60.5% to $0.3836.
    • Phoenix Motor Inc. (NASDAQ:PEV) climbed 48% to $1.48. Phoenix Motor said its EdisonFuture subsidiary launched new Proton Exchange Membrane (PEM) solutions for green hydrogen products and production.
    • Maris-Tech Ltd. (NASDAQ:MTEK) shares climbed 21.1% to $1.2110. Maris-Tech announced its participation in the upcoming Milipol Paris 2023 at the Paris Norde Villepinte exhibition.
    • Senstar Technologies Ltd. (NASDAQ:SNT) surged 20.5% to $1.35.
    • AERWINS Technologies Inc. (NASDAQ:AWIN) gained 19.5% to $0.1688. AERWINS Technologies said its board approved the establishment of a United States subsidiary in Los Angeles, California to pursue the redesign of its XTURISMO Ltd Edition prototype 1 hoverbike.
    • Windtree Therapeutics, Inc. (NASDAQ:WINT) climbed 13.3% to $1.3601.
    • Jin Medical International Ltd. (NASDAQ:ZJYL) rose 16% to $15.93.
    • T2 Biosystems, Inc. (NASDAQ:TTOO) climbed 17% to $0.3075.
    • Vivakor, Inc. (NASDAQ:VIVK) gained 15.6% to $0.96.
    • Singularity Future Technology Ltd. (NASDAQ:SGLY) jumped 15.3% to $0.68.
    • National Western Life Group, Inc. (NASDAQ:NWLI) climbed 13.8% to $474.69 after the company inked a definitive merger deal with Prosperity Life Group for about $1.9 billion in an all-cash transaction.
    • U.S. Energy Corp. (NASDAQ:USEG) climbed 12.2% to $1.38.
    • ContraFect Corporation (NASDAQ:CFRX) surged 11.3% to $0.4454.
    • Northrop Grumman Corporation (NYSE:NOC) gained 10.7% to $468.58. Defense stocks are rising as war breaks out in Israel and Gaza.
    • WW International, Inc. (NASDAQ:WW) gained 9.9% to $11.47.
    • Turnstone Biologics Corp. (NASDAQ:TSBX) gained 9.4% to $2.56.
    • Stabilis Solutions, Inc. (NASDAQ:SLNG) rose 9.1% to $4.84.
    • Lockheed Martin Corporation (NYSE:LMT) climbed 7.8% to $ 432.03 amid conflict in the Middle East.
    • Callon Petroleum Company (NYSE:CPE) gained 6.8% to $35.94 as the Israel-Hamas conflict caused oil supply uncertainty.

    Losers

    • Shift Technologies, Inc. (NASDAQ:SFT) shares fell 86.6% to $0.2551 after the company said it will file for Chapter 11 bankruptcy protection.
    • Falcon's Beyond Global, Inc. (NASDAQ:FBYD) dipped 31.4% to $11.10. Falcon’s Beyond Global closed its previously announced business combination with FAST Acquisition Corp. II.
    • LQR House Inc. (NASDAQ:LQR) fell 27% to $0.28.
    • SaverOne 2014 Ltd (NASDAQ:SVRE) fell 26% to $0.4703.
    • Wheeler Real Estate Investment Trust, Inc. (NASDAQ:WHLR) shares fell 21.8% to $1.00, after declining 18% on Friday.
    • Electriq Power Holdings, Inc. (NYSE:ELIQ) fell 20.3% to $1.3540.
    • Vaccinex, Inc. (NASDAQ:VCNX) declined 20% to $0.8870.
    • MicroCloud Hologram Inc. (NASDAQ:HOLO) declined 18.8% to $0.9498.
    • Addex Therapeutics Ltd (NASDAQ:ADXN) declined 16.6% to $0.3550. Addex announced plan to implement ADS ratio change.
    • Grom Social Enterprises, Inc. (NASDAQ:GROM) fell 13.8% to $1.48.
    • Meiwu Technology Company Limited (NYSE:WNW) fell 13.6% to $0.0992.
    • Tango Therapeutics, Inc. (NASDAQ:TNGX) fell 12.9% to $9.91.
    • Nano-X Imaging Ltd. (NASDAQ:NNOX) declined 11.7% to $6.53.
    • Repare Therapeutics Inc. (NASDAQ:RPTX) fell 10.5% to $6.94.
    • XPeng Inc. (NASDAQ:XPEV) fell 9.6% to $16.41.
    • Spruce Power Holding Corporation (NYSE:SPRU) declined 9.5% to $4.0323.
    • Pagaya Technologies Ltd. (NASDAQ:PGY) declined 9.5% to $1.42.
    • Enviva Inc. (NYSE:EVA) fell 9% to $5.27.
    • Kubient, Inc. (NASDAQ:KBNT) shares fell 8.8% to $0.2498. On Oct. 2, Kubient reduced expenses by implementing an 36% reduction in the company's workforce.
    • Applied Optoelectronics, Inc. (NASDAQ:AAOI) dipped 8.7% to $8.29.
    • Femasys Inc. (NASDAQ:FEMY) shares fell 8.5% to $1.8294.
    • Lithium Americas Corp. (NYSE:LAC) declined 8.4% to $10.52. Stifel initiated coverage on Lithium Americas with a Buy rating and announced a price target of $15.
    • Tempo Automation Holdings, Inc. (NASDAQ:TMPO) shares fell 8.1% to $0.1516 after gaining 18% on Friday.
    • Kamada Ltd. (NASDAQ:KMDA) declined 7.1% to $4.88.
    • Mobileye Global Inc. (NASDAQ:MBLY) fell 6.3% to $38.87 due to conflict in the company's home country, Israel.
    • Mirati Therapeutics, Inc. (NASDAQ:MRTX) shares slipped 5.2% to $57.08 after Bristol Myers Squibb (NYSE:BMY) announced plans to acquire the company in a deal worth up to $5.8 billion. JMP Securities and Jefferies downgraded Mirati Therapeutics following the announcement.
    • Tesla, Inc. (NASDAQ:TSLA) shares fell 2.1% to $255.16. According to a Reuters report citing the China Passenger Car Association, Tesla sold 74,073 China-made vehicles in September, marking a decrease of 10.9% on a year-over-year basis.

     

    Now Read This: Top 5 Industrials Stocks That May Explode In October

    Get the next $AAOI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AAOI
    $ADXN
    $AWIN
    $BMY

    CompanyDatePrice TargetRatingAnalyst
    Tesla Inc.
    $TSLA
    3/4/2026$460.00Buy
    BofA Securities
    Stabilis Solutions Inc.
    $SLNG
    3/4/2026Buy → Hold
    Maxim Group
    Applied Optoelectronics Inc.
    $AAOI
    2/27/2026$55.00Outperform → Market Perform
    Northland Capital
    Applied Optoelectronics Inc.
    $AAOI
    2/27/2026$54.00Sell → Neutral
    B. Riley Securities
    Bristol-Myers Squibb Company
    $BMY
    2/25/2026$60.00Sector Perform
    RBC Capital Mkts
    Tango Therapeutics Inc.
    $TNGX
    2/23/2026$19.00Outperform
    Mizuho
    Bristol-Myers Squibb Company
    $BMY
    2/20/2026$75.00Overweight
    Barclays
    Tesla Inc.
    $TSLA
    2/12/2026$550.00Buy
    Tigress Financial
    More analyst ratings

    $AAOI
    $ADXN
    $AWIN
    $BMY
    SEC Filings

    View All

    SEC Form 424B3 filed by Wheeler Real Estate Investment Trust Inc.

    424B3 - Wheeler Real Estate Investment Trust, Inc. (0001527541) (Filer)

    3/6/26 7:43:59 AM ET
    $WHLR
    Real Estate Investment Trusts
    Real Estate

    SEC Form 424B3 filed by Wheeler Real Estate Investment Trust Inc.

    424B3 - Wheeler Real Estate Investment Trust, Inc. (0001527541) (Filer)

    3/6/26 7:41:45 AM ET
    $WHLR
    Real Estate Investment Trusts
    Real Estate

    Wheeler Real Estate Investment Trust Inc. filed SEC Form 8-K: Other Events

    8-K - Wheeler Real Estate Investment Trust, Inc. (0001527541) (Filer)

    3/6/26 7:38:08 AM ET
    $WHLR
    Real Estate Investment Trusts
    Real Estate

    $AAOI
    $ADXN
    $AWIN
    $BMY
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    September 26, 2024 - FDA Approves Drug with New Mechanism of Action for Treatment of Schizophrenia

    For Immediate Release: September 26, 2024 Today, the U.S. Food and Drug Administration approved Cobenfy (xanomeline and trospium chloride) capsules for oral use for the treatment of schizophrenia in adults. It is the first antipsychotic drug approved to treat schizophrenia that targets cholinergic receptors as opposed to dopamine receptors, which has long been the standard of care.   “Schizophrenia is a leading

    9/26/24 6:42:20 PM ET
    $BMY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    June 14, 2024 - FDA Roundup: June 14, 2024

    For Immediate Release: June 14, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA issued a proposed exemption for certain cottage cheese products from the requirements of the Food Traceability Rule. The proposal would exempt Grade “A” cottage cheese that appears on the Interstate Milk Shippers List from the requirements of the r

    6/14/24 3:54:45 PM ET
    $MMSI
    $BMY
    Medical/Dental Instruments
    Health Care
    Biotechnology: Pharmaceutical Preparations

    March 8, 2024 - FDA Roundup: March 8, 2024

    For Immediate Release: March 08, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA announced proposed new regulations to provide animal drug sponsors with predictable requirements for the labeling of prescription and over-the-counter new animal drugs, as well as new animal drugs for use in animal feeds. The proposed content and

    3/8/24 3:26:46 PM ET
    $BMY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AAOI
    $ADXN
    $AWIN
    $BMY
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    BofA Securities resumed coverage on Tesla with a new price target

    BofA Securities resumed coverage of Tesla with a rating of Buy and set a new price target of $460.00

    3/4/26 8:40:18 AM ET
    $TSLA
    Auto Manufacturing
    Industrials

    Stabilis Solutions downgraded by Maxim Group

    Maxim Group downgraded Stabilis Solutions from Buy to Hold

    3/4/26 8:16:46 AM ET
    $SLNG
    Oil/Gas Transmission
    Utilities

    Applied Optoelectronics downgraded by Northland Capital with a new price target

    Northland Capital downgraded Applied Optoelectronics from Outperform to Market Perform and set a new price target of $55.00

    2/27/26 8:26:41 AM ET
    $AAOI
    Semiconductors
    Technology

    $AAOI
    $ADXN
    $AWIN
    $BMY
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Steel Partners Holdings L.P. bought $51,303 worth of shares (10,208 units at $5.03) (SEC Form 4)

    4 - SPRUCE POWER HOLDING CORP (0001772720) (Issuer)

    12/29/25 5:14:41 PM ET
    $SPRU
    Auto Parts:O.E.M.
    Consumer Discretionary

    Large owner Steel Partners Holdings L.P. bought $85,989 worth of shares (17,033 units at $5.05) (SEC Form 4)

    4 - SPRUCE POWER HOLDING CORP (0001772720) (Issuer)

    12/23/25 4:52:23 PM ET
    $SPRU
    Auto Parts:O.E.M.
    Consumer Discretionary

    Large owner Steel Partners Holdings L.P. bought $486,619 worth of shares (100,822 units at $4.83) (SEC Form 4)

    4 - SPRUCE POWER HOLDING CORP (0001772720) (Issuer)

    11/28/25 4:43:23 PM ET
    $SPRU
    Auto Parts:O.E.M.
    Consumer Discretionary

    $AAOI
    $ADXN
    $AWIN
    $BMY
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Maris-Tech Announces $2.0 Million Registered Direct Offering

    Rehovot, Israel, March 06, 2026 (GLOBE NEWSWIRE) -- Maris-Tech Ltd. (NASDAQ:MTEK, MTEKW)) ("Maris-Tech" or the "Company"), a global leader in video and artificial intelligence ("AI")-based edge computing technology, today announced that it has entered into a securities purchase agreement with an institutional investor for the purchase and sale of 1,605,136 ordinary shares (or pre-funded warrants to purchase ordinary shares in lieu thereof) in a registered direct offering (the "Offering"), at a purchase price of $1.24 per ordinary share. The closing of the Offering is expected to occur on or about March 9, 2026, subject to the satisfaction of customary closing conditions. The gross procee

    3/6/26 6:00:00 AM ET
    $MTEK
    Telecommunications Equipment
    Telecommunications

    Maris-Tech Strengthens Defense Foothold with First Substantial Order from a Leading Defense Loitering Munitions Manufacturer

    This order marks the transition to operational supply of Jupiter Drone edge video processing systems for defense applications Rehovot, Israel, March 05, 2026 (GLOBE NEWSWIRE) -- Maris-Tech Ltd. (NASDAQ:MTEK, MTEKW)) ("Maris-Tech" or the "Company"), a global leader in video and artificial intelligence ("AI")-based edge computing technology, announced on February 19, 2026, that it has received its first substantial production order from a new customer, which is a dominant player in the defense loitering munitions sector. The order follows the successful completion of pilot projects with the customer and initial system validation, marking the first substantial operational supply order. The

    3/5/26 9:13:31 AM ET
    $MTEK
    Telecommunications Equipment
    Telecommunications

    Erasca and Tango Therapeutics Enter into Clinical Collaboration to Evaluate Combination of ERAS-0015 and Vopimetostat

    ERAS-0015, a pan-RAS molecular glue, will be evaluated in combination with PRMT5 inhibitor vopimetostat Tango will sponsor the clinical trial and Erasca will supply ERAS-0015 at no cost SAN DIEGO, March 05, 2026 (GLOBE NEWSWIRE) -- Erasca, Inc. (NASDAQ:ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers, today announced a clinical trial collaboration and supply agreement (CTCSA) with Tango Therapeutics, Inc. (NASDAQ:TNGX, "Tango")) to evaluate Erasca's pan-RAS molecular glue, ERAS-0015, with Tango's PRMT5 inhibitor, vopimetostat (TNG462). "We've disclosed encoura

    3/5/26 7:01:00 AM ET
    $ERAS
    $TNGX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AAOI
    $ADXN
    $AWIN
    $BMY
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Loboa Elizabeth G sold $9,800,605 worth of shares (102,347 units at $95.76), decreasing direct ownership by 83% to 20,523 units (SEC Form 4)

    4 - APPLIED OPTOELECTRONICS, INC. (0001158114) (Issuer)

    3/5/26 5:47:13 PM ET
    $AAOI
    Semiconductors
    Technology

    Director Delaney Cynthia sold $2,058,344 worth of shares (21,000 units at $98.02), decreasing direct ownership by 15% to 116,222 units (SEC Form 4)

    4 - APPLIED OPTOELECTRONICS, INC. (0001158114) (Issuer)

    3/5/26 5:47:00 PM ET
    $AAOI
    Semiconductors
    Technology

    Director Black Richard B sold $306,945 worth of shares (3,231 units at $95.00) (SEC Form 4)

    4 - APPLIED OPTOELECTRONICS, INC. (0001158114) (Issuer)

    3/5/26 5:46:46 PM ET
    $AAOI
    Semiconductors
    Technology

    $AAOI
    $ADXN
    $AWIN
    $BMY
    Financials

    Live finance-specific insights

    View All

    XPENG to Report Fourth Quarter and Fiscal Year 2025 Financial Results on Friday, March 20, 2026

    - Earnings Call Scheduled for 8:00 a.m. ET on March 20, 2026 -GUANGZHOU, China, March 5, 2026 /PRNewswire/ -- XPeng Inc. ((", XPENG", or the ", Company, ", NYSE:XPEV), a leading global AI mobility technology company, today announced that it will report its fourth quarter and fiscal year 2025 unaudited financial results on Friday, March 20, 2026, before the open of U.S. markets. The Company's management will host an earnings conference call at 8:00 AM U.S. Eastern Time on March 20, 2026 (8:00 PM Beijing/Hong Kong Time on March 20, 2026).For participants who wish to join the call by phone, please access the link provided below to complete the pre-registration and dial in 5 minutes prior to the

    3/5/26 4:00:00 AM ET
    $XPEV
    Auto Manufacturing
    Industrials

    NACCO INDUSTRIES ANNOUNCES FOURTH QUARTER AND FULL YEAR 2025 RESULTS

    CLEVELAND, March 4, 2026 /PRNewswire/ -- Q4 Highlights:Gross profit of $12.0 million increased 42% from 2024 on 5% lower revenueOperating profit of $7.6 million up 95% over 2024 and 12% over Q3 2025 Net loss of $3.8 million compared with net income of $7.6 million in 20242025 net loss includes a $6.0 million after-tax, non-cash pension settlement chargeAdjusted EBITDA of $14.3 million improved 59% over 2024 and 14% over Q3 2025FY Highlights:Net income of $17.6 million, or $2.35/share, versus $33.7 million, or $4.55/share, in 2024Adjusted EBITDA of $48.9 million compared with $59.4 million in 2024 2024 included $13.6 million of business interruption insurance recoveriesNACCO Industries® (NYSE

    3/4/26 4:47:00 PM ET
    $LAC
    $NC
    Metal Mining
    Basic Materials
    Coal Mining
    Energy

    Kamada to Announce Fiscal Year and Fourth Quarter 2025 Financial Results on March 11, 2026

    REHOVOT, Israel, and HOBOKEN, N.J., March 04, 2026 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ:KMDA, TASE: KMDA.TA)), a global biopharmaceutical company with a portfolio of marketed products indicated for rare and serious conditions and a leader in the specialty plasma-derived field, today announced that it will release financial results for the fourth quarter and fiscal year that ended December 31, 2025, prior to the open of the U.S. financial markets on Wednesday, March 11, 2026. Kamada's management will host an investment community conference call on Wednesday, March 11, at 8:30am Eastern Time to discuss these results and answer questions. Shareholders and other interested parties may part

    3/4/26 7:00:00 AM ET
    $KMDA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AAOI
    $ADXN
    $AWIN
    $BMY
    Leadership Updates

    Live Leadership Updates

    View All

    Tango Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Highlights

    Initial Phase 1/2 trial data of vopimetostat in combination with Revolution Medicines' RAS(ON) inhibitors in MTAP-deleted pancreatic cancer in 2026 with continued robust patient enrollment New clinical supply agreement with Erasca, plus ongoing Revolution Medicines collaboration, supports potential of vopimetostat as the preferred PRMT5 inhibitor for combination with RAS targeted therapies in oncology Cash position of $343 million as of December 31, 2025, with runway into 2028 beyond anticipated key data inflection points BOSTON, March 05, 2026 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ:TNGX), a clinical-stage biotechnology company committed to discovering and delivering the n

    3/5/26 7:00:00 AM ET
    $TNGX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    ParaZero Strengthens Global Sales Leadership with Appointment of Bat-Sheva Noy as VP

    Kfar Saba, Israel, March 04, 2026 (GLOBE NEWSWIRE) -- ParaZero Technologies Ltd. (NASDAQ:PRZO) (the "company" or "ParaZero"), an aerospace defense company pioneering smart, autonomous solutions for the global manned and unmanned aerial systems (UAS) industry, recently announced the appointment of Bat-Sheva Noy as its new Vice President of Global Sales. Ms. Noy brings more than 20 years of extensive commercial and leadership experience, with particular expertise in strategic planning, market access, and leading cross-functional teams. Most recently, from 2020 to 2025, she served as the Business Unit Lead for Rare Diseases at Pfizer Israel ((a subsidiary of Pfizer Inc., NYSE:PFE). In that

    3/4/26 8:32:00 AM ET
    $PFE
    $PRZO
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Military/Government/Technical
    Industrials

    Military UAV Sector Forecast to Surpass $40+ Billion as Modern Warfare Evolves

    NEW YORK, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Market News Updates News Commentary - Unmanned aerial vehicles (UAVs), commonly known as drones, have become a transformative technology in modern defense and military operations, reshaping strategies from reconnaissance to precision strike capabilities. Military drones offer armed forces enhanced situational awareness, reduced risk to personnel, and cost-efficient mission profiles across surveillance, target acquisition, logistics, and electronic warfare. As autonomous systems incorporating artificial intelligence and advanced sensor suites continue to mature, they are increasingly integral to networked battlefield operations and force multiplie

    2/19/26 8:30:00 AM ET
    $NOC
    $PRZO
    $UAVS
    Industrial Machinery/Components
    Industrials
    Military/Government/Technical
    Aerospace

    $AAOI
    $ADXN
    $AWIN
    $BMY
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Maris-Tech Ltd.

    SC 13G/A - Maris Tech Ltd. (0001872964) (Subject)

    12/13/24 11:34:57 AM ET
    $MTEK
    Telecommunications Equipment
    Telecommunications

    Amendment: SEC Form SC 13D/A filed by Wheeler Real Estate Investment Trust Inc.

    SC 13D/A - Wheeler Real Estate Investment Trust, Inc. (0001527541) (Subject)

    12/9/24 5:54:19 PM ET
    $WHLR
    Real Estate Investment Trusts
    Real Estate

    Amendment: SEC Form SC 13G/A filed by Wheeler Real Estate Investment Trust Inc.

    SC 13G/A - Wheeler Real Estate Investment Trust, Inc. (0001527541) (Subject)

    12/5/24 5:28:41 PM ET
    $WHLR
    Real Estate Investment Trusts
    Real Estate

    $AAOI
    $ADXN
    $AWIN
    $BMY
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    What Does the Recent Purchase at Stabilis Solutions Inc. on Jun 7 Indicate?

    Recently, on June 7, 2024, a notable insider purchase occurred at Stabilis Solutions Inc., as reported in a Form 4 filing by Puhala Andrew Lewis. Mr. Lewis purchased $4,150 worth of shares, acquiring 1,000 units at $4.15 per share. This transaction increased his direct ownership by 3% to 33,618 units. Insider transactions such as this one can provide valuable insights for investors, signaling confidence or positive sentiment from those within the company. Examining the historical insider transactions at Stabilis Solutions Inc., several interesting patterns emerge. In a previous Form 4 filed on May 2, 2023, Puhala Andrew Lewis initiated his ownership stake. This was followed by filings from

    6/10/24 12:45:26 AM ET
    $SLNG
    Oil/Gas Transmission
    Utilities